| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/03/2008 | EP1963507A1 Anti-myosin va sirna and skin depigmentation |
| 09/03/2008 | EP1963250A1 Biphenyl derivatives as selective agonists of gamma rar receptor |
| 09/03/2008 | EP1963249A1 Biphenyl derivatives as selective agonists of gamma rar receptors |
| 09/03/2008 | EP1962866A2 Hydrophobic elastomeric polymer chemistry device for inhibiting the growth of onychomycosis and urushiol-induced allergic contact dermatitis |
| 09/03/2008 | EP1962818A1 Use of a dermatological composition comprising an association of hydroquinone, fluocinolone acetonide and tretinoin for treating skin hyperpigmentation following psoriasis or eczema |
| 09/03/2008 | EP1962622A1 Composition based on triethyl citrate for the prevention of enzymatic hydrolysis of triglycerides |
| 09/03/2008 | EP1701933B1 Novel compounds |
| 09/03/2008 | EP1545516B1 Topical formulation comprising at least 10% of metronidazole in white petrolatum and its use in the anal and rectal region |
| 09/03/2008 | EP1448234B1 Formulations comprising a cephalosporin compound and their use in treating bacterial infections in cats and dogs |
| 09/03/2008 | EP1411978B1 Botulinum toxin in the treatment or prevention of acne |
| 09/03/2008 | EP1363617B1 Cyanoacrylate compositions for therapeutic treatment of wounds requiring revision |
| 09/03/2008 | EP1343781B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/03/2008 | EP1328289B1 Oxidized proteins, their biological activity, and therapeutic and diagnostic measures, which are derived from the active mechanism, from the use of these proteins or from the inhibition thereof |
| 09/03/2008 | EP1299424B1 COLD WATER SOLUBLE $g(b)-GLUCAN PRODUCT AND PROCESS FOR PREPARING THE SAME |
| 09/03/2008 | EP1261349B1 Compounds with chelation affinity and selectivity for first transition series elements and their use |
| 09/03/2008 | EP1126869B1 Methods for regulating angiogenesis and vascular integrity using the trk receptor ligands bdnf, nt-3 and nt-4 |
| 09/03/2008 | CN101257915A Method of inhibiting angiogenesis by using ephrin B2 |
| 09/03/2008 | CN101255162A Adenosine receptor antagonists and methods of making and using the same |
| 09/03/2008 | CN101254289A Skin disease traditional Chinese medicine preparation and novel preparation thereof |
| 09/03/2008 | CN101254285A Chinese medicine decoction for curing flat wart |
| 09/03/2008 | CN101254281A Sub-health herbal medicine pills and method of preparing the same |
| 09/03/2008 | CN101254277A External application paste for curing empyrosis |
| 09/03/2008 | CN101254274A Nano chinese medicinal composition for curing white hair alopecia and preparation |
| 09/03/2008 | CN101254262A Wounds antiphogistic and antalgic plaster |
| 09/03/2008 | CN101254257A Chinese medicinal composition for dispeling warts |
| 09/03/2008 | CN101254251A External use chrisma for curing empyrosis |
| 09/03/2008 | CN101254246A External-used burn and scald treating medicine and its preparation |
| 09/03/2008 | CN101254245A Fast-healing Chinese herbal medicine burns and scald agent |
| 09/03/2008 | CN101254241A Healing composition for treating wart |
| 09/03/2008 | CN101254240A Gene therapy for radically treating hepatitis B |
| 09/03/2008 | CN101254233A Gene therapy for radical curing SARS respiratory disease |
| 09/03/2008 | CN101254223A Pomegranate rind and novel method for improving prostate gland symptoms with carthaginian apple seed extract |
| 09/03/2008 | CN101254213A Conditioned medium and its uses |
| 09/03/2008 | CN101254208A Combination for curing alopecia |
| 09/03/2008 | CN101254203A Pharmaceutical combination for curing acute radiation dermatitis |
| 09/03/2008 | CN101254192A Applications of trichloroisocyanuric acid for preparing medicament for curing bedsore |
| 09/03/2008 | CN101254188A Use of medicament of geldanamycin derivative for preparing medicament for curing chemotherapy induction alopecia |
| 09/03/2008 | CN101254155A Skin preparations for external use |
| 09/03/2008 | CN100415747C Phosphodiesterase 4 inhibitors |
| 09/03/2008 | CN100415744C 2-arylamino-pyrimidines for the treatment of GSK3-related disorders |
| 09/03/2008 | CN100415724C Pyrimidine derivatives |
| 09/03/2008 | CN100415719C 2,5-disubstituted 3-mercaptopentanoic acid |
| 09/03/2008 | CN100415718C CASPASE inhibitors and use thereof |
| 09/03/2008 | CN100415247C Strontium compound for treatment of sub-dermal soft tissue pain |
| 09/03/2008 | CN100415246C Compositions for preparing external carbon dioxide agents |
| 09/03/2008 | CN100415237C Aciclovir compositions containing dimethicone |
| 09/03/2008 | CN100415227C Use of compounds in preparing medicament for treating treating transplant rejection |
| 09/03/2008 | CN100415206C Whitening agent, skin preparation for external use and cosmetic |
| 09/02/2008 | US7420061 Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 09/02/2008 | US7420042 Soluble neuropilin/growth factor receptor fusion proteins |
| 09/02/2008 | US7419999 Gamma lactams as prostaglandin agonists and use thereof |
| 09/02/2008 | US7419998 Therapeutic methods and compositions involving isoflavones |
| 09/02/2008 | US7419987 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them |
| 09/02/2008 | US7419977 e.g. 1-(9-Benzylamino-10-cyano-imidazo[1,2- alpha ]quinoline-2-carbonyl)morpholine; cardiovascular diseases; acylation of imidazo[1,2- alpha]quinoline acid derivatives by morpholine derivatives |
| 09/02/2008 | US7419974 Cyclohexyl(alkyl)propanolamines, preparation method and pharmaceutical compositions containing same |
| 09/02/2008 | US7419970 Cosmetic compositions comprising N-acylamino amides |
| 09/02/2008 | US7419958 Antagonists that bind CD1d and inhibit activation of CD1d-restricted natural killer (NK) T cells, agents that block CD1d-specific receptors and CD1d decoys and a carrier or diluent; contact dermatitis for example |
| 09/02/2008 | US7419799 Medical diagnosis; gene expression; genetic engineering; cell proliferation |
| 09/02/2008 | US7419670 Method of treating arthritis with SERP-1 and an immunosuppressant |
| 09/02/2008 | CA2395037C The use of scopolamine salts |
| 09/02/2008 | CA2388140C Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 09/02/2008 | CA2384922C Topical glycopyrrolate product for the reduction of sweating |
| 09/02/2008 | CA2292910C Hair growth compositions and uses |
| 09/02/2008 | CA2146973C Uses of tgf-.beta. receptor fragment as a therapeutic agent |
| 08/28/2008 | WO2008103613A2 Hydroxylamine compounds and methods of their use |
| 08/28/2008 | WO2008102783A1 Hair regrowth promoter |
| 08/28/2008 | WO2008102584A1 Novel flavanol compound and method for production thereof |
| 08/28/2008 | WO2008102467A1 External preparation for skin |
| 08/28/2008 | WO2008102368A1 Medicinal formulation containing a combination of hiv type i and hiv type ii |
| 08/28/2008 | WO2008101824A1 Imidazo[1',5':1,6] pyrido[3,4-b]indoles derivatives and therapeutical use thereof |
| 08/28/2008 | WO2008101693A2 Cosmetic and pharmaceutical applications of n-acylated amino acids and structurally related compounds |
| 08/28/2008 | WO2008101692A2 Cosmetic and pharmaceutical applications of n-acetylhydroxyproline |
| 08/28/2008 | WO2008019823A3 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins |
| 08/28/2008 | WO2007092720A8 Vitamin d analog: nel, methods and uses thereof |
| 08/28/2008 | US20080207779 Electrically conductive hydrogels |
| 08/28/2008 | US20080207773 Cosmetic, pharmaceutical and dermatological products |
| 08/28/2008 | US20080207771 Topical Compositions |
| 08/28/2008 | US20080207762 Method of treating inflammatory acne vulgaris with carbamide peroxide |
| 08/28/2008 | US20080207753 Antiinflammatory agents; cardiovascular disorders; vision defects; skin disorders; central nervous system disorders; antiarthritic agents |
| 08/28/2008 | US20080207752 Poly (epsilon-caprolactone-co-methylmethacrylate), method for preparing the same using super critical fluid, and method for preparing therapeutic agent for skin diseases such as acne, atopy and athlete's foot comprising the same |
| 08/28/2008 | US20080207750 Use of N-Chlorotaurine for Treatment of Oozing Tissue Deficiencies |
| 08/28/2008 | US20080207746 Administering an ultrasonic contrast agent; imaging tissue; medical diagnosis; using halogenated xanthene compound |
| 08/28/2008 | US20080207733 Composition for the Treatment of Vitiligo |
| 08/28/2008 | US20080207730 Methods of using (+)-2-[1-(3-Ethoxy-4 methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione |
| 08/28/2008 | US20080207725 Skin disorders; antiinflamamtory agenst; antiallergens |
| 08/28/2008 | US20080207680 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents |
| 08/28/2008 | US20080207679 Glutathione peroxidase mimetics for the treatment of dermatoses |
| 08/28/2008 | US20080207672 Skin disorders; administering by mouth, topical, transdermal; using rapamycin compound |
| 08/28/2008 | US20080207670 Dermally Applicable Formulations For Treating Skin Diseases in Animals |
| 08/28/2008 | US20080207656 Methods, compositions, and kits for organ protection during systemic anticancer therapy |
| 08/28/2008 | US20080207642 Respiratory system disorders; asthma; chronic obstructive pulmonary diseases; autoimmune diseases; antiproliferative agents; anticancer agents |
| 08/28/2008 | US20080207628 Methods of preventing and reducing the severity of stress-associated conditions |
| 08/28/2008 | US20080207593 Antihistamine Combination |
| 08/28/2008 | US20080207570 Clobetasol 17-propionate, desonide, or betamethaone valerate; emollient, wax, or fatty alcohol; nonionic surfactant; propylene glycol, dipropylene glycol, propylene glycol dipelargonate, lauroglycol, ethoxydiglycol, urea, acetone, or oleic acid propenetrating agent; nongreasy; psoriasis, skin disorders |
| 08/28/2008 | US20080207560 Blending a phospholipid and a mono- or oligo-glycol ether, together with at least one bioactive component selected from the group consisting of hyaluronic acid and derivatives, vitamin A and derivatives, vitamin C and derivatives, xanthine derivatives, and ubiquinones; improved bioavailability |
| 08/28/2008 | US20080207545 Using antisense oligonucleotides, small interfering RNA, and ribozymes to inhibit expression of the human steroid 5 alpha-reductase gene and thereby inhibit formation of dihydrotestosterone: skin diseases, hair loss, hirsuitism, and benign prostatic hyperplasia |
| 08/28/2008 | US20080207531 Milk or whey is microfiltrated or heat treated; depositing on a cation exchange resin; washing cation exchange resin with demineralized water; elution with brine solutions of increasing conductivity; concentration by ultrafiltration, sterilization, spray drying; psoriasis, autoimmune diseases |
| 08/28/2008 | US20080207526 Synthetic peptides and methods of use for autoimmune disease therapies |
| 08/28/2008 | US20080207519 Administering a p38 MAP kinase phosphorylation inhibitor selected from SB202190, SB203580, RWJ 67657, BIRB796, 681323, SCIO-469, SCIO-323, VX-702, and VX-745; skin and pemphigoid autoimmune blistering disorders; inhibiting heat shock protein pathway; |
| 08/28/2008 | US20080206377 Topical Compositions and Methods For Alleviating or Inhibiting Symptoms Associated With Carpal Tunnel Syndrome, Acid Reflux, Psoriasis, Cartilage Nodules, Fibromyalgia, and Diabetes |